✦ LIBER ✦

Development of Outcome Measures for Large-vessel Vasculitis for Use in Clinical Trials: Opportunities, Challenges, and Research Agenda

✍ Scribed by DIRESKENELI, H.; AYDIN, S. Z.; KERMANI, T. A.; MATTESON, E. L.; BOERS, M.; HERLYN, K.; LUQMANI, R. A.; NEOGI, T.; SEO, P.; SUPPIAH, R.

Book ID: 111902136
Publisher: Journal of Rheumatology Publishing Company
Year: 2011
Tongue: English
Weight: 350 KB
Volume: 38
Category: Article
ISSN: 0315-162X
DOI: 10.3899/jrheum.110275

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The OMERACT Core Set of Outcome Measures

The OMERACT Core Set of Outcome Measures for Use in Clinical Trials of ANCA-associated Vasculitis

✍ MERKEL, P. A.; AYDIN, S. Z.; BOERS, M.; DIRESKENELI, H.; HERLYN, K.; SEO, P.; SU 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 781 KB

Development for and results of the use o

Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial

✍ William O. Williford; William F. Krol; Stuart Jon Spechler 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 669 KB

Development of a recombinant Leishmania

Development of a recombinant Leishmania major strain sensitive to ganciclovir and 5-fluorocytosine for use as a live vaccine challenge in clinical trials

✍ Noushin Davoudi; Celia A. Tate; Corinna Warburton; Angus Murray; Fereidoun Mahbo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 210 KB